Arizona State Retirement System’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $519K | Buy |
57,934
+1,556
| +3% | +$13.9K | ﹤0.01% | 1433 |
|
|
2025
Q1 | $423K | Sell |
56,378
-623
| -1% | -$4.67K | ﹤0.01% | 1504 |
|
|
2024
Q4 | $429K | Buy |
57,001
+3,518
| +7% | +$26.5K | ﹤0.01% | 1572 |
|
|
2024
Q3 | $406K | Buy |
53,483
+1,542
| +3% | +$11.7K | ﹤0.01% | 1594 |
|
|
2024
Q2 | $321K | Buy |
51,941
+1,283
| +3% | +$7.93K | ﹤0.01% | 1667 |
|
|
2024
Q1 | $257K | Sell |
50,658
-2,314
| -4% | -$11.8K | ﹤0.01% | 1794 |
|
|
2023
Q4 | $317K | Sell |
52,972
-823
| -2% | -$4.93K | ﹤0.01% | 1694 |
|
|
2023
Q3 | $381K | Buy |
53,795
+863
| +2% | +$6.11K | ﹤0.01% | 1535 |
|
|
2023
Q2 | $373K | Sell |
52,932
-1,085
| -2% | -$7.64K | ﹤0.01% | 1586 |
|
|
2023
Q1 | $451K | Buy |
54,017
+1,548
| +3% | +$12.9K | ﹤0.01% | 1467 |
|
|
2022
Q4 | $602K | Buy |
52,469
+2,026
| +4% | +$23.3K | 0.01% | 1268 |
|
|
2022
Q3 | $636K | Buy |
50,443
+400
| +0.8% | +$5.04K | 0.01% | 1184 |
|
|
2022
Q2 | $529K | Buy |
50,043
+1,403
| +3% | +$14.8K | 0.01% | 1318 |
|
|
2022
Q1 | $791K | Buy |
48,640
+498
| +1% | +$8.1K | 0.01% | 1193 |
|
|
2021
Q4 | $667K | Sell |
48,142
-261
| -0.5% | -$3.62K | 0.01% | 1363 |
|
|
2021
Q3 | $696K | Buy |
48,403
+321
| +0.7% | +$4.62K | 0.01% | 1329 |
|
|
2021
Q2 | $760K | Sell |
48,082
-3,317
| -6% | -$52.4K | 0.01% | 1296 |
|
|
2021
Q1 | $523K | Buy |
51,399
+195
| +0.4% | +$1.98K | ﹤0.01% | 1512 |
|
|
2020
Q4 | $381K | Sell |
51,204
-1,016
| -2% | -$7.56K | ﹤0.01% | 1607 |
|
|
2020
Q3 | $179K | Buy |
52,220
+17,448
| +50% | +$59.8K | ﹤0.01% | 1808 |
|
|
2020
Q2 | $166K | Sell |
34,772
-1,396
| -4% | -$6.66K | ﹤0.01% | 1698 |
|
|
2020
Q1 | $72K | Buy |
+36,168
| New | +$72K | ﹤0.01% | 1712 |
|